TELUS Health to offer Medworxx Patient Flow Platform to customers

Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) today announced that TELUS Health will now offer customers the Medworxx Patient Flow Platform, enabling health care practitioners to better analyze and monitor patient health in an acute care environment. Comprised of Medworxx Clinical Criteria, Bed Management System, and Forms and Assessments, the platform is available as part of TELUS Health's suite of technology solutions.

"Medworxx is excited to collaborate with TELUS Health and continue to expand Medworxx market penetration," said Dan Matlow, President and CEO, Medworxx. "We look forward to the opportunity this partnership brings in building awareness and adoption of Medworxx technology in our key markets."

Medworxx Patient Flow is a natural complement to Clinical Information Systems (CIS) such as TELUS' OACIS. TELUS Health's OACIS streamlines data through a single, intuitive source where clinicians can access, document and analyze a patient's profile to identify and address their most urgent needs, ultimately increasing efficiency and productivity to deliver better healthcare.

"The addition of Medworxx to TELUS Health's offering will bring additional value to our customers through our synergistic technologies and provide TELUS Health's customers with additional capabilities to help drive proactive decision-making at the point of care," said Kasra Moozar, vice-president, Healthcare Delivery Solutions, TELUS Health. "We are pleased to partner with Medworxx to bring their solutions to our customers as part of our expanding suite of acute care technology."